CoChat

An eye to the future: Researchers debate best path for stem cell-derived therapies

Chakradhar, Shraddha · 2016 · Nature Medicine

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Overview

Integrity signals

Registry

Crossref · 10.1038/nm0216-116

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 1 references

Cited by

See all 56

Metadata

Authors
Chakradhar, S.
Corresponding author
Chakradhar, Shraddha
Venue
Nature Medicine
Published
2016-02
Volume
22
Issue
2
Pages
116-119
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2266236998
Cited by
56
References
1
Citations by year
2025: 5 · 2024: 1 · 2023: 5 · 2022: 10 · 2021: 3 · 2020: 10 · 2019: 3 · 2018: 5 · 2017: 8 · 2016: 6
Type
other
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
Keywords
stem cell transplantation, age-related macular degeneration, dry age-related macular degeneration, visual acuity, tissue engineering, mesenchymal stem cells, pulmonary arterial hypertension, anti-inflammatory activity, immunomodulation
MeSH terms
Human Embryonic Stem Cells, Costs and Cost Analysis, Humans, Macular Degeneration, Mutation, Transplantation, Autologous, Transplantation, Homologous, Stem Cell Transplantation, Biomedical Research, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An eye to the future: Researchers debate best path for stem cell-derived therapies. https://app.cochat.ai/papers/10.1038/nm0216-116
The paper
Chakradhar, S. (2016). An eye to the future: Researchers debate best path for stem cell-derived therapies. Nature Medicine. https://doi.org/10.1038/nm0216-116

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.